Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions.

scientific article published on 29 April 2016

Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/JNCI/DJW039
P932PMC publication ID6059120
P698PubMed publication ID27130933

P50authorBaris TurkbeyQ88769455
Peter L ChoykeQ90059714
Peter A PintoQ90059716
Howard L ParnesQ93104466
Arvin K GeorgeQ96240193
Maria J MerinoQ107749611
Mohummad Minhaj SiddiquiQ37831177
Soroush Rais-BahramiQ40114897
Bradford J. WoodQ40114938
P2093author name stringRachel Rubin
Richard M Simon
P2860cites workESUR prostate MR guidelines 2012Q24620926
Systematic review of complications of prostate biopsyQ26822966
Prostate cancer localization using multiparametric MR imaging: comparison of Prostate Imaging Reporting and Data System (PI-RADS) and Likert scales.Q30650693
Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.Q30664726
Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy.Q36386904
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancerQ37254919
Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigenQ37381526
Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic ReviewQ38278155
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancerQ40114843
Multiparametric magnetic resonance imaging outperforms the Prostate Cancer Prevention Trial risk calculator in predicting clinically significant prostate cancerQ40199490
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.Q45967722
Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective.Q46326701
Prospective Study of Diagnostic Accuracy Comparing Prostate Cancer Detection by Transrectal Ultrasound–Guided Biopsy Versus Magnetic Resonance (MR) Imaging with Subsequent MR-guided Biopsy in Men Without Previous Prostate BiopsiesQ56688802
Value of prostate multiparametric magnetic resonance imaging for predicting biopsy results in first or repeat biopsyQ63966461
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectcancer diagnosisQ110324059
prostate cancerQ181257
biopsyQ179991
P577publication date2016-04-29
P1433published inJournal of the National Cancer InstituteQ400279
P1476titleEfficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions.
P478volume108

Reverse relations

cites work (P2860)
Q92732671Assessment of the Minimal Targeted Biopsy Core Number per MRI Lesion for Improving Prostate Cancer Grading Prediction
Q39446394Co-registration of MRI and ultrasound: accuracy of targeting based on radiology-pathology correlation
Q38376726Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy
Q42366596DNA repair deregulation in discrete prostate cancer lesions identified on multi-parametric MRI and targeted by MRI/ultrasound fusion-guided biopsy
Q58562192Detection of extraprostatic disease and seminal vesicle invasion in patients undergoing magnetic resonance imaging-targeted prostate biopsies
Q52887561Effect of Prostate Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy on Radiation Treatment Recommendations.
Q93177852Evaluation of MSKCC Preprostatectomy nomogram in men who undergo MRI-targeted prostate biopsy prior to radical prostatectomy
Q95261579Evolution of prostate cancer diagnosis: retrospective analysis of magnetic resonance imaging/ultrasound fusion guided biopsies protocol in routine practice and patients management
Q38989771Factors predicting prostate cancer upgrading on magnetic resonance imaging-targeted biopsy in an active surveillance population
Q93025020Financial implications of biparametric prostate MRI
Q38808867Focal Therapy for Prostate Cancer: Pending Questions
Q60923446Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification
Q90257493Impact of prebiopsy magnetic resonance imaging of the prostate on cancer detection and treatment patterns
Q92090246Intercenter reproducibility of software-based fusion biopsies for grade group prediction when targeting suspicious MRI lesions
Q58562086MRI findings guiding selection of active surveillance for prostate cancer: a review of emerging evidence
Q52624219MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?
Q55421492MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men.
Q38377827Missing the Mark: Prostate Cancer Upgrading by Systematic Biopsy over Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Biopsy
Q47252469Multi-institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12-core systematic biopsy
Q42374568Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer
Q39151621Pathological Findings in Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion-guided Biopsy: Relation to Prostate Cancer Focal Therapy
Q58801432Photoacoustic tomography of intact human prostates and vascular texture analysis identify prostate cancer biopsy targets
Q89396666Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies?
Q38843182Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers
Q48159238Role of systematic biopsy in the era of multiparametric magnetic resonance imaging and ultrasound fusion guidance
Q47588633Ruling out clinically significant prostate cancer with negative multi-parametric MRI.
Q57109743Targets missed: predictors of MRI-targeted biopsy failing to accurately localize prostate cancer found on systematic biopsy
Q57107312The Use of Magnetic Resonance Imaging in the Prostate Cancer Primary Diagnostic Pathway: Is It Ready for Primetime?
Q38950693The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy.
Q90428558Which scores need a core? An evaluation of MR-targeted biopsy yield by PIRADS score across different biopsy indications

Search more.